City

Guangzhou (2)

Condition

Validity and Safety (2)

Overall Status

Enrolling by invitation (1)

Recruiting (1)

Sign in for free

Phase

Sponsor

Nanfang Hospital of Southern Medical University (2)

Collaborator

Intervention

dasatinib 100 mg (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Study Type

Observational (2)

validity and safety

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Recruiting

Validity and Safety

Guangzhou, Guangdong, China

NanfangH

Apr 9, 2022

Early Conversion of Dasatinib in CML-CP Patients

Enrolling by invitation

Validity and Safety

Dasatinib 100 MG

Guangzhou, Guangdong, China

NanfangH

Dec 9, 2020